-
Product Insights
New![]()
Hematology Analyzers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Hematology Analyzers Pipeline Market Report Overview Hematology Analyzers consist of analytical laboratory equipment that is used to perform tests related to blood and blood components. These analyzers are also used to identify and determine the morphology of blood and blood-forming cells such as white blood cells, lymphocytes, monocytes, neutrophils, eosinophils, and basophils. Hematology analyzers utilize various technological solutions to recognize cell types in a blood sample and to count them individually to generate a complete blood count (CBC) with differential....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Cobolimab in Hepatocellular Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Cobolimab in Hepatocellular Carcinoma Drug Details: Cobolimab is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Prexigebersen-A in Squamous Cell Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Prexigebersen-A in Squamous Cell Carcinoma Drug Details: Prexigebersen-A is under development for the treatment of...
-
Product Insights
New![]()
Artificial Pancreas Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Artificial Pancreas Pipeline Market Report Overview Artificial Pancreas helps people with diabetes, primarily type 1, automatically and continuously control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas. The artificial pancreas pipeline market research report provides comprehensive information about the products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Territories ·       The US ·       Europe ·       China ·       Australia ·       ...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Hydrocortisone in Adrenal Insufficiency
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hydrocortisone in Adrenal Insufficiency Drug Details: Hydrocortisone (ATRS-1902) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SerpinPC in Hemophilia A (Factor VIII Deficiency)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.SerpinPC in Hemophilia A (Factor VIII Deficiency)Drug Details:SerpinPC is under development for the treatment of haemophilia...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BLU-222 in Ovarian Cancer
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BLU-222 in Ovarian Cancer Drug Details: BLU-222 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – STP-122G in Bleeding And Clotting Disorders
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. STP-122G in Bleeding And Clotting Disorders Drug Details: STP-122G is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TP-1454 in Anal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TP-1454 in Anal Cancer Drug Details: TP-1454 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – XTX-301 in Ovarian Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. XTX-301 in Ovarian Cancer Drug Details: XTX-301 is under development for treatment of solid tumors...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.